Literature DB >> 36120267

COVID-19 Encephalopathy: Delayed Onset in Unvaccinated Patients.

Dana Heller1, Ramesh Pandit2,3, Trupti Pandit4, Gregory P Morris5.   

Abstract

COVID-19 infections have a broad spectrum of severity, with more severe symptoms observed in elderly patients, patients with underlying comorbidities, and patients with unvaccinated status. This case series aims to highlight two cases of unvaccinated patients who developed COVID-19 encephalopathy, contrasted with a vaccinated patient with similar risk factors. This article highlights the unique characteristics of COVID-19 encephalopathy to guide clinicians while approaching the broad diagnosis of acute encephalopathy or altered mental state in hospitalized patients. Current literature was reviewed and summarized the information available regarding encephalopathy separate from the more complex encephalitis and encephalomyelitis.
Copyright © 2022, Heller et al.

Entities:  

Keywords:  altered mental status evaluation; covid-19 vaccination; covid-19-related encephalopathy; duration of hospital stay; elderly population; neurological complication; subacute; unvaccinated

Year:  2022        PMID: 36120267      PMCID: PMC9464455          DOI: 10.7759/cureus.27932

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

Review 1.  Encephalopathy in patients with COVID-19: A review.

Authors:  Ravindra Kumar Garg; Vimal Kumar Paliwal; Ankit Gupta
Journal:  J Med Virol       Date:  2020-07-11       Impact factor: 2.327

Review 2.  A neurologist's approach to delirium: diagnosis and management of toxic metabolic encephalopathies.

Authors:  Vaishnav Krishnan; Lester Y Leung; Louis R Caplan
Journal:  Eur J Intern Med       Date:  2013-12-10       Impact factor: 4.487

Review 3.  What SARS-CoV-2 does to our brains.

Authors:  Tom Aschman; Ronja Mothes; Frank L Heppner; Helena Radbruch
Journal:  Immunity       Date:  2022-06-20       Impact factor: 43.474

Review 4.  Neuroinvasive and neurotropic human respiratory coronaviruses: potential neurovirulent agents in humans.

Authors:  Marc Desforges; Alain Le Coupanec; Elodie Brison; Mathieu Meessen-Pinard; Pierre J Talbot
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

5.  Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy.

Authors:  Asia Filatov; Pamraj Sharma; Fawzi Hindi; Patricio S Espinosa
Journal:  Cureus       Date:  2020-03-21

6.  6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records.

Authors:  Maxime Taquet; John R Geddes; Masud Husain; Sierra Luciano; Paul J Harrison
Journal:  Lancet Psychiatry       Date:  2021-04-01       Impact factor: 27.083

Review 7.  Neurological Complications of COVID-19: Underlying Mechanisms and Management.

Authors:  Ghaydaa A Shehata; Kevin C Lord; Michaela C Grudzinski; Mohamed Elsayed; Ramy Abdelnaby; Hatem A Elshabrawy
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

8.  COVID-19 encephalopathy: an unusual presentation with new-onset seizure causing convulsive status epilepticus.

Authors:  Aisha Fareed Siddiqui; Sheema Saadia; Taymmia Ejaz; Zain Mushtaq
Journal:  BMJ Case Rep       Date:  2022-03-08

9.  Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Authors:  Alberto Paniz-Mondolfi; Clare Bryce; Zachary Grimes; Ronald E Gordon; Jason Reidy; John Lednicky; Emilia Mia Sordillo; Mary Fowkes
Journal:  J Med Virol       Date:  2020-07       Impact factor: 20.693

10.  COVID-19-related encephalopathy: a case series with brain FDG-positron-emission tomography/computed tomography findings.

Authors:  C Delorme; O Paccoud; A Kas; A Hesters; S Bombois; P Shambrook; A Boullet; D Doukhi; L Le Guennec; N Godefroy; R Maatoug; P Fossati; B Millet; V Navarro; G Bruneteau; S Demeret; V Pourcher
Journal:  Eur J Neurol       Date:  2020-09-22       Impact factor: 6.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.